Technical Analysis for ARCT - Arcturus Therapeutics Ltd.

Grade Last Price % Change Price Change
C 25.44 -6.47% -1.76
ARCT closed down 6.47 percent on Thursday, September 28, 2023, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down

Date Alert Name Type % Chg
Oversold Stochastic Weakness 0.00%
NR7 Range Contraction -6.47%
Inside Day Range Contraction -6.47%
Oversold Stochastic Weakness -6.47%
Gapped Up Strength -4.83%
Oversold Stochastic Weakness -4.83%
Oversold Stochastic Weakness -3.09%
Lower Bollinger Band Walk Weakness -6.61%
Oversold Stochastic Weakness -6.61%
Stochastic Buy Signal Bullish -5.50%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Lower Bollinger Band Support about 8 hours ago
Down 1 ATR about 13 hours ago
60 Minute Opening Range Breakdown about 14 hours ago
Down 5% about 14 hours ago
Down 3% about 14 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Arcturus Therapeutics Ltd. Description

Alcobra Ltd is a development-stage biopharmaceutical company. The Company is focused on development and commercialization of its lead product candidates, including MDX and ADAIR. MDX is a oral drug, for the treatment of ADHD and other cognitive disorders, including Fragile X. MDX is a combined rapid onset ER formulation of the chemical pyridoxine pyroglutamate, which is more commonly known as metadoxine. MDX consists of a single bi-layer oral tablet, which includes both a rapid onset release metadoxine formulation and a slow release metadoxine formulation together providing the desired dual release profile. The new extended-release formulation prolongs the human plasma levels of metadoxine for up to 12 hours, which results in enhanced efficacy benefits. ADAIR is an oral, semi-solid, liquid-filled, hard gelatin capsule of an abuse-deterrent IR formulation of dextroamphetamine sulfate, which is manufactured as 10 mg capsules.


Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Health Sciences Drugs Pharmacology Euphoriants Amphetamine Cognitive Disorders Glutamate Tablet Adhd Taar1 Agonists

Is ARCT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 37.75
52 Week Low 13.83
Average Volume 406,105
200-Day Moving Average 24.81
50-Day Moving Average 30.63
20-Day Moving Average 28.91
10-Day Moving Average 26.98
Average True Range 1.60
RSI (14) 35.48
ADX 20.32
+DI 13.95
-DI 30.18
Chandelier Exit (Long, 3 ATRs) 28.33
Chandelier Exit (Short, 3 ATRs) 29.92
Upper Bollinger Bands 33.13
Lower Bollinger Band 24.68
Percent B (%b) 0.09
BandWidth 29.23
MACD Line -1.26
MACD Signal Line -0.97
MACD Histogram -0.2884
Fundamentals Value
Market Cap 623.1 Million
Num Shares 24.5 Million
EPS -1.26
Price-to-Earnings (P/E) Ratio -20.17
Price-to-Sales 140.45
Price-to-Book 7.63
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 28.43
Resistance 3 (R3) 28.65 27.88 27.93
Resistance 2 (R2) 27.88 27.12 27.77 27.76
Resistance 1 (R1) 26.66 26.65 26.28 26.44 27.60
Pivot Point 25.89 25.89 25.70 25.78 25.89
Support 1 (S1) 24.67 25.13 24.29 24.45 23.28
Support 2 (S2) 23.90 24.66 23.79 23.12
Support 3 (S3) 22.68 23.90 22.95
Support 4 (S4) 22.46